[1]
|
Micali, G., Lacarrubba, F., Musumeci, M.L., et al. (2010) Cutaneous Vascular Patterns in Psoriasis. International Journal of Dermatology, 49, 249-256. https://doi.org/10.1111/j.1365-4632.2009.04287.x
|
[2]
|
Heidenreich, R., Rocken, M. and Ghoreschi, K. (2009) Angiogenesis Drives Psoriasis Pathogenesis. International Journal of Experimental Pathology, 90, 232-248. https://doi.org/10.1111/j.1365-2613.2009.00669.x
|
[3]
|
Dudley, A.C. and Griffioen, A.W. (2023) Pathological Angiogenesis: Mechanisms and Therapeutic Strategies. Angiogenesis, 26, 313-347. https://doi.org/10.1007/s10456-023-09876-7
|
[4]
|
Xian, D., Song, J., Yang, L., et al. (2019) Emerging Roles of Redox-Mediated Angiogenesis and Oxidative Stress in Dermatoses. Oxidative Medicine and Cellular Longevity, 2019, Article ID: 2304018. https://doi.org/10.1155/2019/2304018
|
[5]
|
Dudley, A.C. and Griffioen, A.W. (2023) The Modes of Angiogenesis: An Updated Perspective. Angiogenesis, 26, 477-480. https://doi.org/10.1007/s10456-023-09895-4
|
[6]
|
Hoeben, A., Landuyt, B., Highley, M.S., et al. (2004) Vascular Endothelial Growth Factor and Angiogenesis. Pharmacological Reviews, 56, 549-580. https://doi.org/10.1124/pr.56.4.3
|
[7]
|
Adini, A., Adini, I., Chi, Z.L., et al. (2017) A Novel Strategy to Enhance Angiogenesis in vivo Using the Small VEGF-Binding Peptide PR1P. Angiogenesis, 20, 399-408. https://doi.org/10.1007/s10456-017-9556-7
|
[8]
|
Sajib, S., Zahra, F.T., Lionakis, M.S., et al. (2018) Mechanisms of Angiogenesis in Microbe-Regulated Inflammatory and Neoplastic Conditions. Angiogenesis, 21, 1-14. https://doi.org/10.1007/s10456-017-9583-4
|
[9]
|
Granata, F., Frattini, A., Loffredo, S., et al. (2010) Production of Vascular Endothelial Growth Factors from Human Lung Macrophages Induced by Group IIA and Group X Secreted Phospholipases A2. The Journal of Immunology, 184, 5232-5241. https://doi.org/10.4049/jimmunol.0902501
|
[10]
|
Genovese, A., Detoraki, A., Granata, F., et al. (2012) Angiogenesis, Lymphangiogenesis and Atopic Dermatitis. Chemical Immunology and Allergy, 96, 50-60. https://doi.org/10.1159/000331883
|
[11]
|
Richarz, N.A., Boada, A. and Carrascosa, J.M. (2017) Angiogenesis in Dermatology—Insights of Molecular Mechanisms and Latest Developments. Actas Dermo-Sifiliográficas, 108, 515-523. https://doi.org/10.1016/j.ad.2016.12.001
|
[12]
|
Viallard, C. and Larrivée, B. (2017) Tumor Angiogenesis and Vascular Normalization: Alternative Therapeutic Targets. Angiogenesis, 20, 409-426. https://doi.org/10.1007/s10456-017-9562-9
|
[13]
|
Lee, H.J., Hong, Y.J. and Kim, M. (2021) Angiogenesis in Chronic Inflammatory Skin Disorders. International Journal of Molecular Sciences, 22, Article 12035. https://doi.org/10.3390/ijms222112035
|
[14]
|
Marina, M.E., Roman, I.I., Constantin, A.M., et al. (2015) VEGF Involvement in Psoriasis. Clujul Medical, 88, 247-252. https://doi.org/10.15386/cjmed-494
|
[15]
|
Luengas-Martinez, A., Paus, R. and Young, H.S. (2022) Antivascular Endothelial Growth Factor-A Therapy: A Novel Personalized Treatment Approach for Psoriasis. British Journal of Dermatology, 186, 782-791. https://doi.org/10.1111/bjd.20940
|
[16]
|
Song, M. and Finley, S.D. (2018) Mechanistic Insight into Activation of MAPK Signaling by Pro-Angiogenic Factors. BMC Systems Biology, 12, Article No. 145. https://doi.org/10.1186/s12918-018-0668-5
|
[17]
|
Jiang, M., Li, B., Zhang, J., et al. (2017) Vascular Endothelial Growth Factor Driving Aberrant Keratin Expression Pattern Contributes to the Pathogenesis of Psoriasis. Experimental Cell Research, 360, 310-319. https://doi.org/10.1016/j.yexcr.2017.09.021
|
[18]
|
Wen, J., Wang, X., Pei, H., et al. (2015) Anti-Psoriatic Effects of Honokiol through the Inhibition of NF-κB and VEGFR-2 in Animal Model of K14-VEGF Transgenic Mouse. Journal of Pharmacological Sciences, 128, 116-124. https://doi.org/10.1016/j.jphs.2015.05.008
|
[19]
|
Guo, D., Murdoch, C.E., Liu, T., et al. (2018) Therapeutic Angiogenesis of Chinese Herbal Medicines in Ischemic Heart Disease: A Review. Frontiers in Pharmacology, 9, Article 428. https://doi.org/10.3389/fphar.2018.00428
|
[20]
|
Bosch, J., Abraldes, J.G., Fernández, M., et al. (2010) Hepatic Endothelial Dysfunction and Abnormal Angiogenesis: New Targets in the Treatment of Portal Hypertension. Journal of Hepatology, 53, 558-567. https://doi.org/10.1016/j.jhep.2010.03.021
|
[21]
|
Yang, L., Fan, X., Cui, T., et al. (2017) Nrf2 Promotes Keratinocyte Proliferation in Psoriasis through Up-Regulation of Keratin 6, Keratin 16, and Keratin 17. Journal of Investigative Dermatology, 137, 2168-2176. https://doi.org/10.1016/j.jid.2017.05.015
|
[22]
|
Calautti, E., Avalle, L. and Poli, V. (2018) Psoriasis: A STAT3-Centric View. International Journal of Molecular Sciences, 19, Article 171. https://doi.org/10.3390/ijms19010171
|
[23]
|
Yang, L., Li, B., Dang, E., et al. (2016) Impaired Function of Regulatory T Cells in Patients with Psoriasis Is Mediated by Phosphorylation of STAT3. Journal of Dermatological Science, 81, 85-92. https://doi.org/10.1016/j.jdermsci.2015.11.007
|
[24]
|
Huang, X., Yu, P., Liu, M., et al. (2019) ERK Inhibitor JSI287 Alleviates Imiquimod-Induced Mice Skin Lesions by ERK/IL-17 Signaling Pathway. International Immunopharmacology, 66, 236-241. https://doi.org/10.1016/j.intimp.2018.11.031
|
[25]
|
Sakurai, K., Dainichi, T., Garcet, S., et al. (2019) Cutaneous p38 Mitogen-Activated Protein Kinase Activation Triggers Psoriatic Dermatitis. Journal of Allergy and Clinical Immunology, 144, 1036-1049. https://doi.org/10.1016/j.jaci.2019.06.019
|
[26]
|
Aksamitiene, E., Kiyatkin, A. and Kholodenko, B.N. (2012) Cross-Talk between Mitogenic Ras/MAPK and Survival PI3K/Akt Pathways: A Fine Balance. Biochemical Society Transactions, 40, 139-146. https://doi.org/10.1042/BST20110609
|
[27]
|
Fruman, D.A., Chiu, H., Hopkins, B.D., et al. (2017) The PI3K Pathway in Human Disease. Cell, 170, 605-635. https://doi.org/10.1016/j.cell.2017.07.029
|
[28]
|
Pike, M.C., Lee, C.S., Elder, J.T., et al. (1989) Increased Phosphatidylinositol Kinase Activity in Psoriatic Epidermis. Journal of Investigative Dermatology, 92, 791-797. https://doi.org/10.1111/1523-1747.ep12696808
|
[29]
|
Dharaneeswaran, H., Abid, M.R., Yuan, L., et al. (2014) FOXO1-Mediated Activation of Akt Plays a Critical Role in Vascular Homeostasis. Circulation Research, 115, 238-251. https://doi.org/10.1161/CIRCRESAHA.115.303227
|
[30]
|
Zhang, M. and Zhang, X. (2019) The Role of PI3K/AKT/FOXO Signaling in Psoriasis. Archives of Dermatological Research, 311, 83-91. https://doi.org/10.1007/s00403-018-1879-8
|
[31]
|
Liu, Y., Luo, W. and Chen, S. (2011) Comparison of Gene Expression Profiles Reveals Aberrant Expression of FOXO1, Aurora A/B and EZH2 in Lesional Psoriatic Skins. Molecular Biology Re-ports, 38, 4219-4224. https://doi.org/10.1007/s11033-010-0544-x
|
[32]
|
Teng, Y., Fan, Y., Ma, J., et al. (2021) The PI3K/Akt Pathway: Emerging Roles in Skin Homeostasis and a Group of Non-Malignant Skin Disorders. Cells, 10, Article 1219. https://doi.org/10.3390/cells10051219
|
[33]
|
Li, Y., Man, X., You, L., et al. (2014) Downregulation of PTEN Expression in Psoriatic Lesions. International Journal of Dermatology, 53, 855-860. https://doi.org/10.1111/ijd.12061
|
[34]
|
Jimenez, L., Amenabar, C., Mayoral-Varo, V., et al. (2022) mTORC2 Is the Major Second Layer Kinase Negatively Regulating FOXO3 Activity. Molecules, 27, Article 5414. https://doi.org/10.3390/molecules27175414
|
[35]
|
Mitra, A., Raychaudhuri, S.K. and Raychaudhuri, S.P. (2012) IL-22 Induced Cell Proliferation Is Regulated by PI3K/Akt/mTOR Signaling Cascade. Cytokine, 60, 38-42. https://doi.org/10.1016/j.cyto.2012.06.316
|
[36]
|
Lowes, M.A., Russell, C.B., Martin, D.A., Towne, J.E. and Krueger, J.G. (2013) The IL-23/T17 Pathogenic Axis in Psoriasis Is Amplified by Keratinocyte Responses. Trends in Immunology, 34, 174-181. https://doi.org/10.1016/j.it.2012.11.005
|
[37]
|
Finkel, T. and Holbrook, N.J. (2000) Oxidants, Oxidative Stress and the Biology of Ageing. Nature, 408, 239-247. https://doi.org/10.1038/35041687
|
[38]
|
Long, M., Yang, S.H., Han, J.X., et al. (2016) The Protective Effect of Grape-Seed Proanthocyanidin Extract on Oxidative Damage Induced by Zearalenone in Kunming Mice Liver. International Journal of Molecular Sciences, 17, Article 808. https://doi.org/10.3390/ijms17060808
|
[39]
|
Balamurugan, K. (2016) HIF-1 at the Crossroads of Hypoxia, Inflammation, and Cancer. International Journal of Cancer, 138, 1058-1066. https://doi.org/10.1002/ijc.29519
|
[40]
|
Yu, B., Wang, X., Song, Y., et al. (2022) The Role of Hypoxia-Inducible Factors in Cardiovascular Diseases. Pharmacology & Therapeutics, 238, Article ID: 108186. https://doi.org/10.1016/j.pharmthera.2022.108186
|
[41]
|
Nofal, A., Al-Makhzangy, I., Attwa, E., et al. (2009) Vascular Endothelial Growth Factor in Psoriasis: An Indicator of Disease Severity and Control. Journal of the European Academy of Dermatology and Venereology, 23, 803-806. https://doi.org/10.1111/j.1468-3083.2009.03181.x
|
[42]
|
Campanati, A., Goteri, G., Simonetti, O., et al. (2009) Angiogenesis in Psoriatic Skin and Its Modifications after Administration of Etanercept: Videocapillaroscopic, Histological and Immunohistochemical Evaluation. International Journal of Immunopathology and Pharmacology, 22, 371-377. https://doi.org/10.1177/039463200902200214
|
[43]
|
Detmar, M., Brown, L.F., Schon, M.P., et al. (1998) Increased Microvascular Density and Enhanced Leukocyte Rolling and Adhesion in the Skin of VEGF Transgenic Mice. Journal of Investigative Dermatology, 111, 1-6. https://doi.org/10.1046/j.1523-1747.1998.00262.x
|
[44]
|
Armstrong, A.W., Voyles, S.V., Armstrong, E.J., et al. (2011) Angiogenesis and Oxidative Stress: Common Mechanisms Linking Psoriasis with Atherosclerosis. Journal of Dermatological Science, 63, 1-9. https://doi.org/10.1016/j.jdermsci.2011.04.007
|
[45]
|
Lacarrubba, F., Pellacani, G., Gurgone, S., et al. (2015) Advances in Non-Invasive Techniques as Aids to the Diagnosis and Monitoring of Therapeutic Response in Plaque Psoriasis: A Review. International Journal of Dermatology, 54, 626-634. https://doi.org/10.1111/ijd.12870
|
[46]
|
Stinco, G., Lautieri, S., Valent, F., et al. (2007) Cutaneous Vascular Alterations in Psoriatic Patients Treated with Cyclosporine. Acta Dermato-Venereologica, 87, 152-154. https://doi.org/10.2340/00015555-0216
|
[47]
|
Stinco, G., Buligan, C., Maione, V., et al. (2013) Videocapillaroscopic Findings in the Microcirculation of the Psoriatic Plaque during Etanercept Therapy. Clinical and Experimental Dermatology, 38, 633-637. https://doi.org/10.1111/ced.12036
|
[48]
|
Stinco, G., Lautieri, S., Piccirillo, F., Valent, F. and Patrone, P. (2009) Response of Cutaneous Microcirculation to Treatment with Mometasone Furoate in Patients with Psoriasis. Clinical and Experimental Dermatology, 34, 915-919. https://doi.org/10.1111/j.1365-2230.2009.03298.x
|
[49]
|
Stinco, G., Buligan, C., Errichetti, E., et al. (2013) Clinical and Capillaroscopic Modifications of the Psoriatic Plaque during Therapy: Observations with Oral Acitretin. Dermatology Research and Practice, 2013, Article ID: 781942. https://doi.org/10.1155/2013/781942
|
[50]
|
Archid, R., Duerr, H.P., Patzelt, A., et al. (2016) Relationship between Histological and Clinical Course of Psoriasis: A Pilot Investigation by Reflectance Confocal Microscopy during Goeckerman Treatment. Skin Pharmacology and Physiology, 29, 47-54. https://doi.org/10.1159/000443211
|
[51]
|
Micali, G., Lacarrubba, F., Santagati, C., et al. (2016) Clinical, Ultrasound, and Videodermatoscopy Monitoring of Psoriatic Patients Following Biological Treatment. Skin Research and Technology, 22, 341-348. https://doi.org/10.1111/srt.12271
|
[52]
|
Musumeci, M.L., Lacarrubba, F., Fusto, C.M. and Micali, G. (2013) Combined Clinical, Capillaroscopic and Ultrasound Evaluation During Treatment of Plaque Psoriasis with Oral Cyclosporine. International Journal of Immunopathology and Pharmacology, 26, 1027-1033. https://doi.org/10.1177/039463201302600425
|
[53]
|
Muralidharan, E., Malhotra, S.K. and Singh, A. (2021) Can Dermoscopy and Ultrasonography Be Considered a Prognostic Tool in Management of Psoriasis? Indian Journal of Dermatology, 66, 704. https://doi.org/10.4103/ijd.ijd_1088_20
|
[54]
|
Wang, T., Zhu, Q. and Ding, J. (2019) Clinical Effect of Mometasone Furoate Cream Combined with Moisturizer in the Treatment of Psoriasis Vulgaris. Chinese Contemporary Medicine, 26, 51-53.
|
[55]
|
Qi, W. and Jia, K. (2022) Observation on the Efficacy of Liangxue Xiaomalao Decoction Combined with Conventional Treatment in Patients with Psoriasis Vulgaris. Medical Clinical Research, 39, 1436-1438.
|
[56]
|
Zhang, Q., Li, G., Liu, B., et al. (2021) Observation on the Efficacy of Babaowudan Medicinal Ink Combined with Calcipotriol Ointment in the Treatment of Guttate Psoriasis in Children. Chinese Journal of Integrated Traditional Chinese and Western Medicine Dermatology and Venereology, 20, 474-476.
|
[57]
|
Shen, J., Li, G., Zhang, Q., et al. (2020) Dermoscopic Observation and Analysis of the Effect and Analysis of Topical Drugs in the Treatment of Psoriasis Vulgaris. Chinese Journal of Dermatology and Venereology, 34, 401-404.
|
[58]
|
Liu, X., Zhang, J., Kong, X., et al. (2019) Dermoscopic Dynamic Observation of the Correlation between Vascular Changes and Skin Lesion Changes before and after Psoriasis Treatment. Chinese Journal of Dermatology and Venereology, 33, 32-37.
|
[59]
|
Liu, X., Li, J., Yu, Y., et al. (2022) Dermoscopic Observation of the Effect and Efficacy of Traditional Chinese Medicine in the Treatment of Psoriasis Vulgaris. Chinese Journal of Integrated Traditional Chinese and Western Medicine Dermatology and Venereology, 21, 502-505.
|
[60]
|
Dini, V., Janowska, A., Faita, F., et al. (2021) Ultra-High-Frequency Ultrasound Monitoring of Plaque Psoriasis during Ixekizumab Treatment. Skin Research and Technology, 27, 277-282. https://doi.org/10.1111/srt.12942
|
[61]
|
Yélamos, O., Alejo, B., Ertekin, S.S., et al. (2021) Non-Invasive Clinical and Microscopic Evaluation of the Response to Treatment with Clobetasol Cream vs. Calcipotriol/Betamethasone Dipropionate Foam in Mild to Moderate Plaque Psoriasis: An Investigator-Initiated, Phase IV, Unicentric, Open, Randomized Clinical Trial. Journal of the European Academy of Dermatology and Venereology, 35, 143-149. https://doi.org/10.1111/jdv.16559
|
[62]
|
Basaran, Y.K., Gürel, M.S., Erdemir, A.T., et al. (2015) Evaluation of the Response to Treatment of Psoriasis Vulgaris with Reflectance Confocal Microscopy. Skin Research and Technology, 21, 18-24. https://doi.org/10.1111/srt.12150
|
[63]
|
Errichetti, E., Croatto, M., Arnoldo, L., et al. (2020) Plaque-Type Psoriasis Treated with Calcipotriene plus Betamethasone Dipropionate Aerosol Foam: A Prospective Study on Clinical and Dermoscopic Predictor Factors in Response Achievement and Retention. Dermatology and Therapy, 10, 757-767. https://doi.org/10.1007/s13555-020-00406-7
|
[64]
|
Errichetti, E. and Stinco, G. (2018) Clinical and Dermoscopic Response Predictors in Psoriatic Patients Undergoing Narrowband Ultraviolet B Phototherapy: Results from a Prospective Study. International Journal of Dermatology, 57, 681-686. https://doi.org/10.1111/ijd.13983
|
[65]
|
El, S.M., Lotfi, R., Hossam, D., Onsy, P. and Elhawatky, A. (2023) Assessment of Vascular Patterns during the Treatment of Psoriatic Patients Using Narrow-Band Ultraviolet B Phototherapy by the Dermoscope. Photodermatology, Photoimmunology & Photomedicine, 39, 100-106. https://doi.org/10.1111/phpp.12855
|
[66]
|
Lallas, A., Argenziano, G., Zalaudek, I., et al. (2016) Dermoscopic Hemorrhagic Dots: An Early Predictor of Response of Psoriasis to Biologic Agents. Dermatology Practical & Conceptual, 6, 7-12. https://doi.org/10.5826/dpc.0604a02
|
[67]
|
Madhukar Phiske, M. (2016) Scalp Psoriasis: A Brief Overview. Journal of Cosmetology & Trichology, 2, Article ID: 1000110. https://doi.org/10.4172/2471-9323.1000110
|
[68]
|
Brandon, A., Mufti, A., et al. (2019) Diagnosis and Management of Cutaneous Psoriasis: A Review. Advances in Skin & Wound Care, 32, 58-69. https://doi.org/10.1097/01.ASW.0000550592.08674.43
|
[69]
|
Luengas-Martinez, A., Hardman-Smart, J., Paus, R. and Young H.S., (2020) Vascular Endothelial Growth Factor-A as a Promising Therapeutic Target for the Management of Psoriasis. Experimental Dermatology, 29, 687-698. https://doi.org/10.1111/exd.14151
|